Physician profile
Daniel U Kim
NPI 1942286976
$251.25
in general payments reported to CMS, 2019-2025
8 companies · $17.30 in 2025
The $17.30 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.29 · 2020: $78.12 · 2021: $78.28 · 2022: $35.54 · 2023: $15.72 · 2025: $17.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.63 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $64.88 | 2019-2025 | Bridion |
| Shionogi INC | $20.65 | 2020 | |
| Baudax Bio INC. | $20.05 | 2021 | |
| Karl Storz Endoscopy-America | $12.84 | 2021 | |
| Janssen Biotech, INC. | $12.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.35 | 2020 | |
| Antares Pharma, INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.